SCHEMBL1960227

SCHEMBL1960227

COC(=O)c1sccc1[As](C(=O)c1ccc(Cl)cc1Cl)C1CCN(C)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.42
▸ MAPT P10636 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ TP53 P04637 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ USP2 O75604 2/20 0.37
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1960198 0.77 CACNA2D1 (0.45) RAB9AMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL14223408 0.67 KMT2A (0.68) RAB9AMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL25131450 0.66 ALDH1A1 (0.46) MAPTALDH1A1SMN1; SMN2NPC1NPSR1
SCHEMBL16866362 0.65 MAPT (0.44) RAB9AMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL1961677 0.65 SMN1; SMN2 (0.53) MAPTALDH1A1SMN1; SMN2NPC1NPSR1
SCHEMBL608814 0.64 ABL1 (0.68) RAB9AMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL12578860 0.64 CACNA2D1 (0.39) RAB9AALDH1A1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL4159892 0.64 MAPT (0.45) RAB9AMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL1156444 0.63 LMNA (0.77) RAB9ATP53POLBLMNAALOX15
SCHEMBL16870274 0.62 RAB9A (0.47) RAB9AMAPTALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2504329-A1 5-ALKYNYL-THIOPHENE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS Vertex Pharmaceuticals Incorporated (US) 2012-10-03 — — EP disclosed
WO-2011068715-A1 5-ALKYNYL-THIOPHENE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-09 — — WO disclosed
Send feedback